Home > ±³½Ç10³â»ç > ÇÐȸȰµ¿ > Çмú´ëȸ
2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
[ Çмú´ëȸ : 2000 ]
¹ß Ç¥ ÀÚ ÇÐ ¼ú ¹ß Ç¥ Á¦ ¸ñ ¹ßÇ¥ÇÐȸ/ÀÏ ½Ã
Choe BY, Baik HM, Kim MC, Son BC, Ha SH, Kim BS Metabolic alterations in patients with Levodopa-treated Parkinson's diseases by in vivo 1H MRS 8th International Society of Magnetic Resonance in Medicine (ISMRM), Denver, Colorado, April 1-7, 2000
Baik HM, Choe BY, Kim MC, Son BC, Ha SH, Kim BS Metabolic changes in Parkinsons disease after stereotactic functional neurosurgery by follow-up 1H MRS 8th International Society of Magnetic Resonance in Medicine (ISMRM), Denver, Colorado, April 1-7, 2000
Choe BY Trends of high field MRI systems 4th International Symposium of Catholic Research Institutes of Medical Science, Seoul, May 24, 2000
Lee HK Digital Radiography Based on Amorphous Silicon Pixel  Detectors,49-51 4th International Symposium of Catholic Research Institutes of Medical Science, Seoul, May 24, 2000
Park J, Suh TS, Choe BY, Lee HK, Shinn KS Search of the Optimum Beam Position and Size in Radiation Treatment 2000 World Congress on Medical Physics and Biomedical Engineering, Chicago, USA, July, 2000
Shin DH, Suh TS, Lee HK, Choe BY, Shinn KS Optimal Localization and Image Fusion for DSA/CT/MRI 2000 World Congress on Medical Physics and Biomedical Engineering, Chicago, USA, July, 2000
Suh TS, Cho KH, Kim HN, Choe BY, Lee HK, Shinn KS Dosimetric Evaluatuin with/without a Flattening Filter in Stereotactic Radiosurgery 2000 World Congress on Medical Physics and Biomedical Engineering, Chicago, USA, July, 2000
Suh TS Research of Optimum Beam Position and Field Sizes in RT/SRS 3th BMRC Symposium. Seoul, Korea,  Aug. 17, 2000
Suh TS Optimal Localization & Image Fusion for DSA/CT/MRI 3th BMRC Symposium. Seoul, Korea,  Aug. 17, 2000
Song JY, Lee HK Program Development for Quantification Analysis of Nuclear Medicine Image & Application to a Renal Function Study,86-94 3th BMRC Symposium. Seoul, Korea, Aug. 17, 2000
Cho G, Kim HK, Lee SW, Kim DK, Lee HK, Joo KS Monte Carlo Analyses of X-ray Absorption, Noise and Detective Quantum Efficiency Considering Therapeutic X-ray Spectrum in Portal Imaging Detector 2000 IEEE Medical Imaging Conference, Lyon, France, Oct 15, 2000
ÃÖº¸¿µ, ÀÌâ¿í, ¹éÀÎÈ£, ÀÌÈï±Ô, ¼­Å¼®, ÀÌÇü±¸, ½Å°æ¼· Neuronal Abnormalities in patients with chronic alcoholism evaluated by in vivo 1H MRS. Á¦16ȸ Çѱ¹ÀÚ±â°ø¸íÇÐȸ ÀÚ±â°ø¸íÇмú¹ßǥȸ, Ãæ³²´ëÇб³, 2¿ù 11ÀÏ, 2000
¹éÇö¸¸, ÃÖº¸¿µ, ÀÌÇü±¸, ¼­Å¼®, ½Å°æ¼·, ÀÌÈï±Ô Spectral changes of proton metablites induced by perturbed field inhomogeniety in 1H MRS. Á¦16ȸ Çѱ¹ÀÚ±â°ø¸íÇÐȸ ÀÚ±â°ø¸íÇмú¹ßǥȸ, Ãæ³²´ëÇб³, 2¿ù 11ÀÏ, 2000
ÇϽÂÈÆ, ÃÖº¸¿µ, ÀÌÇü±¸, ¼­Å¼®, ½Å°æ¼·, ¼­Å¼®, ÀÌÈï±Ô Development of TEM head-size resonator for 3T MRI head coil. Á¦16ȸ Çѱ¹ÀÚ±â°ø¸íÇÐȸ ÀÚ±â°ø¸íÇмú¹ßǥȸ, Ãæ³²´ëÇб³, 2¿ù 11ÀÏ, 2000
±è  ÅÂ, ¼­Å¼®, ÃÖº¸¿µ, ÀÌÈï±Ô, ½Å°æ¼· Metabolic changes in human brain with fMRI and 1H MRS. Á¦16ȸ Çѱ¹ÀÚ±â°ø¸íÇÐȸ ÀÚ±â°ø¸íÇмú¹ßǥȸ, Ãæ³²´ëÇб³, 2¿ù 11ÀÏ, 2000
±è  ÅÂ, ±èÀdzç, Ã߸íÀÚ, ÃÖº¸¿µ, ¼­Å¼®, ½Å°æ¼· fMRI and the PMA and the SMA due to the effects of Hyperoxemia. Á¦16ȸ Çѱ¹ÀÚ±â°ø¸íÇÐȸ ÀÚ±â°ø¸íÇмú¹ßǥȸ, Ãæ³²´ëÇб³, 2¿ù 11ÀÏ, 2000
±è  ÅÂ, ¼­Å¼®, ÃÖº¸¿µ, ½Å°æ¼·, ÀÌÈï±Ô The optimum TE in fMRI at 1.5T adn 3.0T MRIs. Á¦16ȸ Çѱ¹ÀÚ±â°ø¸íÇÐȸ ÀÚ±â°ø¸íÇмú¹ßǥȸ, Ãæ³²´ëÇб³, 2¿ù 11ÀÏ, 2000
ÃÖº¸¿µ, ½Å°æ¼·, ±èÀdzç, ±è  ÅÂ, ¹éÇö¸¸, ÀÌÇѼ÷ 3T MRI system °³¹ß ¹× ÀÓ»óÀÀ¿ë Á¦5Â÷ ¸Þµð½¼ µ¿°è MRI ¿öÅ©¼¥, ȫõ ¸Þµð½¼, 2¿ù 14-15, 2000³â
¼­Å¼® ¹ÚÁ¤ÈÆ, ÃÖº¸¿µ, ÀÌÇü±¸, ½Å°æ¼·, À±¼¼Ã¶ Comparison of dose distribution between Flattening and nonflattening filter based radiosurgery ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ Á¤À§¹æ»ç¼± Ä¡·á¿¬±¸È¸ Çмú¹ßǥȸ, 2¿ù 2000³â
¼­Å¼®, ¹ÚÁ¤ÈÆ, ÃÖº¸¿µ, ÀÌÇü±¸, ½Å°æ¼·, À±¼¼Ã¶ New Approach to dose Optimization with Additional Constraints ´ëÇÑ ¹æ»ç¼±Á¾¾çÇÐȸ Á¤À§¹æ»ç¼± Ä¡·á¿¬±¸È¸ Çмú¹ßǥȸ, 2¿ù 2000³â
¼­Å¼®, ÀÌÇü±¸, ÃÖº¸¿µ, ½Åµ¿ÈÆ, ½Å°æ¼·, À±¼¼Ã¶ Optimal Localization & Image Fusion for DSA/CT/MRI ´ëÇÑ ¹æ»ç¼±Á¾¾çÇÐȸ Á¤À§¹æ»ç¼± Ä¡·á¿¬±¸È¸ Çмú¹ßǥȸ, 2¿ù 2000³â
±è¼ºÇö, ÀÌÇü±¸ ¼­Å¼®, ½Å°æ¼· Flat Panel Digital Radiography ´ëÇѵðÁöÅпµ»ó±â¼úÇÐȸ, ¼­¿ï,   »ï¼º¼­¿ïº´¿ø, 3¿ù 10ÀÏ, 2000³â 
ÃÖº¸¿µ, ¼­Å¼®, ½Å°æ¼· Ultrafast MRI Techniques. Á¦ 4Â÷ ´ëÇÑÀÚ±â°ø¸íÀÇ°úÇÐȸ ¿¬¼¼´ë °øÇаü, 3¿ù 18ÀÏ, 2000³â
ÃÖº¸¿µ, ½Å°æ¼·, ¹éÇö¸¸, ±è  Å °íÀÚÀå 3.0T MRI °³¹ß ¹× ÀÓ»óÀÀ¿ë  »ê¾÷ÀÚ¿øºÎ ÀüÀÚ»ê¾÷ Àü·«±â¼ú°³¹ß »ç¾÷, ¿øÁÖ ¿ÀÅ©º§¸® 7¿ù 13-14ÀÏ, 2000
ÃÖº¸¿µ ÀÚ±â°ø¸íºÐ±¤ÀÇ ¿ø¸®¿Í ÀÓ»óÀÀ¿ë ´ëÇѳ»°úÇÐȸ ¿¬¼ö°­Á °¡Å縯ÀÇ°úÇבּ¸¿ø 9¿ù 2ÀÏ, 2000
¹ÚÁ¤ÈÆ, ¼­Å¼®, ÃÖº¸¿µ, ÀÌÇü±¸, ½Å°æ¼· ¹æ»ç¼±Ä¡·á½Ã ÃÖÀûÀÇ ºö À§Ä¡¿Í Å©±â°áÁ¤ Á¦21ȸ Çѱ¹ÀÇÇй°¸®ÇÐȸ Ãß°èÇмú ´ëȸ, ¿¬¼¼´ë 9¿ù 22-23ÀÏ, 2000
¼ÛÁÖ¿µ, ÀÌÇü±¸, ¼­Å¼®, ÃÖº¸¿µ, ½Å°æ¼· Development of program for renal function study with quantification analysis of nuclear medicine image Á¦21ȸ Çѱ¹ÀÇÇй°¸®ÇÐȸ Ãß°èÇмú ´ëȸ, ¿¬¼¼´ë 9¿ù 22-23ÀÏ, 2000¡¤
½Åµ¿ÈÆ, ¼­Å¼®, Çã¼ø¿µ, ¼Õº´Ã¶, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼· Optimal localization in DSA/CT/MRI through distortion correction Á¦21ȸ Çѱ¹ÀÇÇй°¸®ÇÐȸ Ãß°èÇмú ´ëȸ, ¿¬¼¼´ë 9¿ù 22-23ÀÏ, 2000
±èÇö¹Ì, ÀÌÇü±¸, ¼­Å¼®, ÃÖº¸¿µ, ½Å°æ¼· ÇÙÀÇÇпµ»ó󸮸¦ À§ÇÑ ÇÁ·Î±×·¥ °³¹ß Á¦21ȸ Çѱ¹ÀÇÇй°¸®ÇÐȸ Ãß°èÇмú ´ëȸ, ¿¬¼¼´ë 9¿ù 22-23ÀÏ, 2000
Ã߸íÀÚ, ±è  ÅÂ, ¼­Å¼®, ½Å½Â¾Ö, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼· SPEC¿µ»ó°ú fMRI ¿µ»óÀ» ÀÌ¿ëÇÑ ½Ã°¢ÀÚ±Ø ¹ÝÀÀ¿¡ ´ëÇÑ ºñ±³ ¿¬±¸ Á¦21ȸ Çѱ¹ÀÇÇй°¸®ÇÐȸ Ãß°èÇмú ´ëȸ, ¿¬¼¼´ë 9¿ù 22-23ÀÏ, 2000
¹éÇö¸¸, ÃÖº¸¿µ, ¼­Å¼®, ÀÌÇü±¸, ½Å°æ¼· Effects of poor shimming on quantitative measurement of metabolite levels in vivo MR spectroscopy Á¦21ȸ Çѱ¹ÀÇÇй°¸®ÇÐȸ Ãß°èÇмú ´ëȸ, ¿¬¼¼´ë 9¿ù 22-23ÀÏ, 2000
ÀÌÀºÁ¤, º¯À翵, ±è¹ü¼ö, ³²±Ã¼ºÀº, ÃÖº¸¿µ, ¼­Å¼®, ÀÌÇü±¸, ½Å°æ¼· Assessment of early stage endometrial carcinoma using t2-weighted and Gd-enhanced T1-weighted MR images Á¦21ȸ Çѱ¹ÀÇÇй°¸®ÇÐȸ Ãß°èÇмú ´ëȸ, ¿¬¼¼´ë 9¿ù 22-23ÀÏ, 2000
ÃÖº¸¿µ, ±èÀdzç, ¼­Å¼®, ÀÌÇü±¸, ÀüÈïÀç, ½Å°æ¼· Present status of high field 3T MRI system Á¦21ȸ Çѱ¹ÀÇÇй°¸®ÇÐȸ Ãß°èÇмú ´ëȸ, ¿¬¼¼´ë 9¿ù 22-23ÀÏ, 2000
ÀüÈïÀç, ÁÖõ±â, ±èÃáÈ£, ÃÖº¸¿µ, ÀÌÇü±¸, ¼­Å¼®, ½Å°æ¼· Biocompatibility profiles of surface modified PMMA IOLs Á¦21ȸ Çѱ¹ÀÇÇй°¸®ÇÐȸ Ãß°èÇмú ´ëȸ, ¿¬¼¼´ë 9¿ù 22-23ÀÏ, 2000
ÀüÈïÀç, ÁÖõ±â, ±èÃáÈ£, ÃÖº¸¿µ, ÀÌÇü±¸, ¼­Å¼®, ½Å°æ¼· Studies on silicon oil adhesion to the surface of intraocular lenses: an FTIR and ESCA studies comparing various IOLs Á¦21ȸ Çѱ¹ÀÇÇй°¸®ÇÐȸ Ãß°èÇмú ´ëȸ, ¿¬¼¼´ë 9¿ù 22-23ÀÏ, 2000
ÀüÈïÀç, ÁÖõ±â, ±èÃáÈ£, ÃÖº¸¿µ, ÀÌÇü±¸, ¼­Å¼®, ½Å°æ¼· Studies on silicon oil adhesion to the surface of intraocular lenses: An FTIR and ESCA studies comparing various IOLs.    Á¦9Â÷ Çѱ¹»ýüÀç·áÇÐȸ Çмú´ëȸ, °í·Á´ë °ø´ë °øÇаü, 9¿ù 23ÀÏ, 2000
ÃÖº¸¿µ ÀÚ±â°ø¸í¿µ»ó ¿ø¸® ¹× ÀÓ»óÀÀ¿ë Çѱ¹°úÇбâ¼ú¿ø, ÀÇ°úÇבּ¸¿ø Ư°­, ´ëÀü KAIST 9¿ù 28ÀÏ, 2000
ÃÖº¸¿µ ÇÙÀÚ±â°ø¸íºÐ±¤ ¿ø¸® ¹× ÀÓ»óÀÀ¿ë Çѱ¹°úÇбâ¼ú¿ø, ÀÇ°úÇבּ¸¿ø Ư°­, ´ëÀü KAIST 10¿ù 5ÀÏ, 2000
¼­Å¼® ¹ÚÀ忬, ¼­´ö¿µ, ÇÑÈñÁ¤, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼· Optimal Localization in DSA/CT/MRI through distortion cirrection ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ Á¤±âÇмú´ëȸ, 10¿ù 2000³â
¼­Å¼® ¹ÚÀ忬, ¼­´ö¿µ, ÇÑÈñÁ¤, ÃÖº¸¿µ, ½Å°æ¼· Web-based 2Â÷¿ø Ä¡·á°èȹ ½Ã½ºÅÛ °³¹ß ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ Á¤±âÇмú´ëȸ, 10¿ù 2000³â
¹ÚÁ¤ÈÆ, ¼­Å¼®, ÃÖº¸¿µ, ÀÌÇü±¸, ½Å°æ¼· ¸ñÀûÇÔ¼ö¸¦ ÀÌ¿ëÇÑ ¹æ»ç¼±·®ºÐÆ÷ ÃÖÀûÈ­ÀÇ ±¸Çö 2000³âµµ ´ëÇѹæ»ç¼±¹æ¾îÇÐȸ Ãß°èÇмú´ëȸ, Á¶¼±´ë 11¿ù 3ÀÏ, 2000
½Åµ¿ÈÆ, ¼­Å¼®, Çã¼ø³ç, ¼Õº´Ã¶, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼· Optimal localization through DSA distortion correction for SRS 2000³âµµ ´ëÇѹæ»ç¼±¹æ¾îÇÐȸ Ãß°èÇмú´ëȸ, Á¶¼±´ë 11¿ù 3ÀÏ, 2000
¼ÛÁÖ¿µ, ÀÌÇü±¸, ¼­Å¼®, ÃÖº¸¿µ, ½Å°æ¼·, Á¤¼ö±³, ±è¼ºÈÆ ÇÙÀÇÇÐ ¿µ»óÀÇ Á¤·®Àû ºÐ¼®À» ÅëÇÑ ½ÅÀå ±â´É Æò°¡ ÇÁ·Î±×·¥ °³¹ß   2000³âµµ ´ëÇѹæ»ç¼±¹æ¾îÇÐȸ Ãß°èÇмú´ëȸ, Á¶¼±´ë 11¿ù 3ÀÏ, 2000
¼­Å¼®, ¹ÚÀ忬, ¼­´ö¿µ, ÇÑÈñÁ¤, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼· PC¸¦ ÀÌ¿ëÇÑ 3Â÷¿ø ¹æ»ç¼± Ä¡·á°èȹÀåÄ¡ ÇÁ·ÎÅäŸÀÔ °³¹ß  2000³âµµ ´ëÇѹæ»ç¼±¹æ¾îÇÐȸ Ãß°èÇмú´ëȸ, Á¶¼±´ë 11¿ù 3ÀÏ, 2000
ÃÖº¸¿µ, ±èÀdzç, ¼­Å¼®, ÀÌÇü±¸, ÀÌÈï±Ô, ÀüÈïÀç, ½Å°æ¼· Present status of high field 3T MRI system Á¦5Â÷ ´ëÇÑÀÚ±â°ø¸íÀÇ°úÇÐȸ Ãß°èÇмú´ëȸ, ¿¬¼¼´ëÀÇ·á¿ø, 11¿ù 4ÀÏ, 2000
¹éÇö¸¸, ÃÖº¸¿µ, ¼­Å¼®, ÀÌÇü±¸, ½Å°æ¼· Effects of poor shimming on quantitative measurements of metabolite levels in vivo by H-1 MRS Á¦5Â÷ ´ëÇÑÀÚ±â°ø¸íÀÇ°úÇÐȸ Ãß°èÇмú´ëȸ, ¿¬¼¼´ëÀÇ·á¿ø, 11¿ù 4ÀÏ, 2000
¹éÇö¸¸, ¼Õº´Ã¶, ¼­Å¼®, ÀÌÇü±¸, ½Å°æ¼·, ÃÖº¸¿µ Proton magnetic resonance spectroscopy of the primary motor cortex in patients with hemiparesis Á¦5Â÷ ´ëÇÑÀÚ±â°ø¸íÀÇ°úÇÐȸ Ãß°èÇмú´ëȸ, ¿¬¼¼´ëÀÇ·á¿ø, 11¿ù 4ÀÏ, 2000
±è»ó¹¬, ÃÖº¸¿µ, ¿ÀâÇö, ¾Èâ¹ü 3D- Medical image rendering using Laplace equation Á¦5Â÷ ´ëÇÑÀÚ±â°ø¸íÀÇ°úÇÐȸ Ãß°èÇмú´ëȸ, ¿¬¼¼´ëÀÇ·á¿ø, 11¿ù 4ÀÏ, 2000
¼Õº´Ã¶, ±è¹®Âù, ÃÖº´±æ, ±èÀdzç, ¹éÇö¸¸, ÃÖº¸¿µ, Shoji Naruse, °­Áرâ Proton magnetic resonance chemical shift imaging (H-1-CSI)-directed stereotactic biopsy Á¦5Â÷ ´ëÇÑÀÚ±â°ø¸íÀÇ°úÇÐȸ Ãß°èÇмú´ëȸ, ¿¬¼¼´ëÀÇ·á¿ø, 11¿ù 4ÀÏ, 2000
Ã߸íÀÚ, ¼­Å¼®, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼· SPECT¿µ»ó°ú fMRI ¿µ»óÀ» ÀÌ¿ëÇÑ ½Ã°¢ ÀÚ±Ø ¹ÝÀÀ¿¡ ´ëÇÑ ºñ±³¿¬±¸ Á¦5Â÷ ´ëÇÑÀÚ±â°ø¸íÀÇ°úÇÐȸ Ãß°èÇмú´ëȸ, ¿¬¼¼´ëÀÇ·á¿ø, 11¿ù 4ÀÏ, 2000
ÀÌÀºÁ¤, º¯À翵, ±è¹ü¼ö, ³²±Ã¼ºÀº, ÃÖº¸¿µ, ¼­Å¼®, ÀÌÇü±¸, ½Å°æ¼·   Assessment of early stage endometrial carcinoma using  T2-weighted and Gd-enhanced T1-weighted MR imaging    Á¦5Â÷ ´ëÇÑÀÚ±â°ø¸íÀÇ°úÇÐȸ Ãß°èÇмú´ëȸ, ¿¬¼¼´ëÀÇ·á¿ø, 11¿ù 4ÀÏ, 2000
¹ÚÁ¤ÈÆ, ¼­Å¼®, ÃÖº¸¿µ, ÀÌÇü±¸, ½Å°æ¼· ¹æ»ç¼± Ä¡·á½Ã ÃÖÀûÀÇ ºö À§Ä¡¿Í Å©±â ¿¬±¸ Á¦23ȸ ´ëÇÑÀÇ¿ë»ýü°øÇÐȸ Ãß°èÇмú´ëȸ, ¼­¿ï ¿Ã¸²ÇÈÆÄÅ©ÅÚ, 11¿ù 10ÀÏ, 2000
¼­Å¼®, ¹ÚÀ忬, ¼­´ö¿µ, ÇÑÈñÁ¤, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼· PC¸¦ ÀÌ¿ëÇÑ 3Â÷¿ø ¹æ»ç¼± Ä¡·á°èÈø ÀåÄ¡ °³¹ß Á¦23ȸ ´ëÇÑÀÇ¿ë»ýü°øÇÐȸ Ãß°èÇмú´ëȸ, ¼­¿ï ¿Ã¸²ÇÈÆÄÅ©ÅÚ, 11¿ù 10ÀÏ, 2000
±èÇö¹Ì, ÀÌÇü±¸, ¼­Å¼®, ÃÖº¸¿µ, ½Å°æ¼·, Á¤¼ö±³, ±è¼ºÈÆ ÇÙÀÇÇÐ ¿µ»ó󸮸¦ À§ÇÑ ÇÁ·Î±×·¥ °³¹ß Á¦23ȸ ´ëÇÑÀÇ¿ë»ýü°øÇÐȸ Ãß°èÇмú´ëȸ, ¼­¿ï ¿Ã¸²ÇÈÆÄÅ©ÅÚ, 11¿ù 10ÀÏ, 2000
¼ÛÁÖ¿µ, ÀÌÇü±¸, ¼­Å¼®, ÃÖº¸¿µ, ½Å°æ¼·, Á¤¼ö±³, ±è¼ºÈÆ ÇÙÀÇÇÐ ¿µ»óÀÇ Á¤·®Àû ºÐ¼®À» ÅëÇÑ ½ÅÀå±â´É Æò°¡ ÇÁ·Î±×·¥ °³¹ß Á¦23ȸ ´ëÇÑÀÇ¿ë»ýü°øÇÐȸ Ãß°èÇмú´ëȸ, ¼­¿ï ¿Ã¸²ÇÈÆÄÅ©ÅÚ, 11¿ù 10ÀÏ, 2000
½Åµ¿ÈÆ, ¼­Å¼®, Çã¼ø¿µ, ¼Õº´Ã¶, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼·   DSA/CT/MR ¿µ»ó¿¡¼­ ÃÖÀûÀÇ Á¾¾ç À§Ä¡ °áÁ¤ Á¦23ȸ ´ëÇÑÀÇ¿ë»ýü°øÇÐȸ Ãß°èÇмú´ëȸ, ¼­¿ï ¿Ã¸²ÇÈÆÄÅ©ÅÚ, 11¿ù 10ÀÏ, 2000
Ã߸íÀÚ, ¼­Å¼®, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼· SPEC ¿µ»ó°ú fMRI ¿µ»óÀ» ÀÌ¿ëÇÑ ½Ã°¢ÀÚ±Ø ¹ÝÀÀ¿¡ ´ëÇÑ ºñ±³ ¿¬±¸ Á¦23ȸ ´ëÇÑÀÇ¿ë»ýü°øÇÐȸ Ãß°èÇмú´ëȸ, ¼­¿ï ¿Ã¸²ÇÈÆÄÅ©ÅÚ, 11¿ù 10ÀÏ, 2000
űâ½Ä, ¼­Å¼®, ÃÖº¸¿µ, ÀÌÇü±¸, ½Å°æ¼·, ÀÌÀç¹® ÀÚ±â°ø¸í¿µ»óÀÇ ÀÚµ¿ºÐÈ°À» ÀÌ¿ëÇÑ ½ÉÀå±â´É ºÐ¼® ÀåÄ¡ Æò°¡ Á¦23ȸ ´ëÇÑÀÇ¿ë»ýü°øÇÐȸ Ãß°èÇмú´ëȸ, ¼­¿ï ¿Ã¸²ÇÈÆÄÅ©ÅÚ, 11¿ù 10ÀÏ, 2000
¼­Å¼® ¹ÚÀ忬, ¼­´ö¿µ, ÇÑÈñÁ¤, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼· ÀÓ»óÀÇÇаú ÀÇ°øÇÐÀÇÈ¿°úÀûÀÎ Çù·Â¹æ¾È Á¦23ȸ ´ëÇÑÀÇ¿ë»ýü°øÇÐȸ Ãß°èÇмú´ëȸ, ¼­¿ï ¿Ã¸²ÇÈÆÄÅ©ÅÚ, 11¿ù 10ÀÏ, 2000
¹ÚÁ¤ÈÆ, ¼­Å¼®, ÃÖº¸¿µ, ÀÌÇü±¸, ½Å°æ¼· ¹æ»ç¼± Ä¡·áÈ®Àοë ÀüÀÚ½Ä °í ¿¡³ÊÁö X-¼± ¿µ»óÀåÄ¡ÀÇ °³¹ß Á¦23ȸ ´ëÇÑÀÇ¿ë»ýü°øÇÐȸ Ãß°èÇмú´ëȸ, ¼­¿ï ¿Ã¸²ÇÈÆÄÅ©ÅÚ, 11¿ù 10ÀÏ, 2000
Ã߸íÀÚ, ¼­Å¼®, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼· SPECT ¿µ»ó°ú fMRI ¿µ»óÀ» ÀÌ¿ëÇÑ ½Ã°¢ÀÚ±Ø ¹ÝÀÀ¿¡ ´ëÇÑ ºñ±³¿¬±¸ Á¦23ȸ ´ëÇÑÀÇ¿ë»ýü°øÇÐȸ Ãß°èÇмú´ëȸ, ¼­¿ï ¿Ã¸²ÇÈÆÄÅ©ÅÚ, 11¿ù 10ÀÏ, 2000
¼­Å¼®, ¹ÚÀ忬, ¼­´ö¿µ, ÇÑÈñÁ¤, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼· An Improved Block Iterative Algorithm for Bayesian Tomographic Reconstruction Using Ordered Subsets Á¦23ȸ ´ëÇÑÀÇ¿ë»ýü°øÇÐȸ Ãß°èÇмú´ëȸ, ¼­¿ï ¿Ã¸²ÇÈÆÄÅ©ÅÚ, 11¿ù 10ÀÏ, 2000
ÃÖº¸¿µ 3T MRI ÀÓ»ó¿µ»ó 3TÄÁ¼Ò½Ã¿ò ¼³¸íȸ, °¡Å縯ÀÇ°úÇÐ ¿¬±¸¿ø 11¿ù 15ÀÏ, 2000³â
¼­Å¼® ¹ÚÀ忬, ¼­´ö¿µ, ÇÑÈñÁ¤, ÀÌÇü±¸, ÃÖº¸¿µ, ½Å°æ¼· 3Â÷¿ø ¹æ»ç¼± Ä¡·á°èȹ½Ã½ºÅÛ °³¹ß ¼º°ú¹°Àü½Ãȸ 2000 º¸°ÇÀÇ·á±â¼úÁøÈï»ç¾÷ ¿¬±¸¹ßǥȸ, 12¿ù, 2000³â
 
 
¼­¿ï½Ã ¼­Ãʱ¸ ¹ÝÆ÷´ë·Î222 °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇ°øÇб³½Ç 06591
TEL : 02-3147-8888 / FAX : 02-3147-8632 / URL : http://www.bme-cmc.or.kr